White House Government Agencies

More

  • *Gold below $1,170/ oz as dollar strength hurts. SINGAPORE, Oct 20- Gold extended losses to a fourth straight session on Tuesday on a stronger dollar and fears the Federal Reserve could still raise U.S. rates this year. Gold touched a 3-1/ 2- month high last week on bets the Fed would not raise U.S. rates amid concerns about the global economy.

  • SINGAPORE, Oct 20- Gold steadied after three days of losses on Tuesday but remained under pressure as the dollar was well bid on expectations the Federal Reserve could still raise U.S. rates this year. *Spot gold was little changed at $1,170.06 an ounce by 0029 GMT, after losing about 1.2 percent in the past three sessions. *Gold touched its highest level in 3-1/ 2...

  • Oct 19- Neos Therapeutics Inc said the U.S. Food and Drug Administration identified deficiencies that preclude discussion of labeling and marketing requirements for the company's treatment of a common type of behavioral disorder. The FDA has not provided any information regarding the nature of the deficiencies, the company said. The notification does not...

  • Oct 19- Neos Therapeutics Inc said the U.S. Food and Drug Administration has identified deficiencies that preclude discussion of labeling and marketing requirements for the company's treatment of a common type of behavioral disorder. The notification does not reflect a final decision on the information under review, the FDA informed the company.

  • NEW YORK, Oct 19- U.S. derivatives regulators charged a Chicago- based trader and his firm on Monday with using a manipulative trading tactic known as "spoofing" in the futures market across four different exchanges. The Commodity Futures Trading Commission, in a civil lawsuit against Igor Oystacher and his proprietary trading firm 3 Red Trading LLC, said the...

  • *Patient who died had received Zafgen's drug. Oct 16 (Reuters)- Zafgen Inc said the U.S. Food and Drug Administration has put a partial hold on the development of its obesity treatment and confirmed that the 22- year-old patient who died during a late-stage study had been taking the drug. Due to previously reported instances of severe blood clotting in ongoing and...

  • Oct 19- U.S. banking regulators should try to make it easier for small lenders to comply with rules aimed at making the nation's financial system more stable, Federal Reserve Governor Lael Brainard said on Monday. "We can reduce burden where possible, particularly for community banks," Brainard said in prepared remarks that did not touch on the outlook for the U.S....

  • Trump, Bush continue battle over 9/11 and George W Monday, 19 Oct 2015 | 8:17 AM ET
    Real estate tycoon Donald Trump (L) and former Florida governor Jeb Bush (R) arrive on stage for the Republican presidential primary debate on August 6, 2015 at the Quicken Loans Arena in Cleveland, Ohio.

    Donald Trump and Jeb Bush aren't done talking about George W. Bush just yet.

  • *Gold drops for third session. SINGAPORE, Oct 19- Gold extended loses to a third straight session on Monday, as strong data on U.S. consumer sentiment prompted investors to pare bets the Federal Reserve will wait until next year to raise interest rates. "Gold is tracking the dollar at the moment," said a trader in Hong Kong.

  • TOKYO, Oct 19- The dollar was steady against the yen and euro on Friday after stronger-than-expected U.S. data kept alive prospects of the Federal Reserve raising interest rates before year-end. The greenback dipped to as low as 119.15 as Tokyo shares began the session significantly lower, but pared its losses as equities regained some of the ground they shed.

  • SINGAPORE, Oct 19- Gold held below a 3-1/ 2- month high on Monday, as mixed U.S. economic data added to uncertainty over whether the Federal Reserve would raise interest rates this year. *Spot gold was steady at $1,176.11 an ounce by 0052 GMT, after dipping 0.5 percent on Friday on a stronger dollar. *Other data, however, showed a drop in assets of SPDR Gold Trust, the top...

  • TOKYO, Oct 19- The dollar was steady against the yen and euro early on Friday after stronger-than-expected U.S. data kept alive prospects of the Federal Reserve raising interest rates before year-end. The greenback had hit a 7- week low of 118.065 yen while the euro had risen to a 7- week peak of $1.1495 earlier last week after downbeat U.S. indicators and concerns...

  • Oct 16- The U.S. Food and Drug Administration notified Shire Plc it will not approve its eye drug Lifitegrast, the company said on Friday, adding that the U.S. health regulator recommended the company conduct additional clinical studies. The news comes over a week before the FDA was supposed to make a decision on Lifitegrast on Oct 25. Shire said it received a...

  • Oct 16- The U.S. Food and Drug Administration notified Shire Plc it will not approve its eye drug Lifitegrast, the company said on Friday, adding that the U.S. health regulator recommended the company conduct additional clinical studies. Shire said it received a complete response letter, which the FDA sends to let a drug developer know a marketing application...

  • DIARY-Top Economic Events to Oct 30 Friday, 16 Oct 2015 | 8:01 PM ET

    CHICAGO- The board of governors of the Federal Reserve System, the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation hold a joint meeting on the Economic Growth and Paperwork Reduction Act of 1996 regulations- 1400 GMT. RICHMOND- Federal Reserve Bank of Richmond President Jeffrey Lacker speaks on "Early Childhood...

  • NEW YORK, Oct 16- The dollar rose broadly on Friday, as traders reckoned the Federal Reserve might raise interest rates later this year and the European Central Bank may provide more stimulus to help the euro zone economy. "I don't think the inflation data was instrumental but at the margin it pushes in that direction," said Adam Cole, RBC Capital Markets' head of FX...

  • The FDA in 2010 approved Pradaxa to prevent stroke in patients with a common heart rhythm irregularity called atrial fibrillation. Praxbind, an intravenous injection, is the first reversal agent approved specifically for Pradaxa and works by binding to the drug compound to neutralize it, the FDA said. Portola Pharmaceuticals Inc plans before the end of 2015...

  • Oct 16- The U.S. Food and Drug Administration on Friday gave accelerated approval to privately held Boehringer Ingelheim's Praxbind to be used in patients who are given the blood thinner drug Pradaxa. Praxbind is used to reverse the blood thinning effects of Pradaxa in patients during emergency situations. The FDA approved Pradaxa in 2010 to prevent stroke...

  • WASHINGTON, Oct 16- The U.S. Federal Communications Commission on Friday released opening bid prices for its airwaves auction in a public notice and also set the dates for broadcasters to file applications for the auction. "For all practical purposes, we've fired the starting gun: the release of final opening bid prices- combined with the detailed application...

  • WASHINGTON, Oct 16- The U.S. Federal Communications Commission on Friday released opening bid prices for its airwaves auction in a public notice and also set the dates for broadcasters to file applications for the auction. Applications to participate in the reverse auction must be filed between Dec. 1 and Dec. 18, according to the notice, which said that late...